Correction to: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype (Nature Cell Biology, (2015), 17, 9, (1205-1217), 10.1038/ncb3225);mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype

Nature Cell Biology

Volumn 17, Issue 9, 2015, Pages 1205-1217

  Herranz, Nicolás ^a   Gallage, Suchira ^a   Mellone, Massimiliano ^b   Wuestefeld, Torsten ^c,h   Klotz, Sabrina ^c   Hanley, Christopher J ^b   Raguz, Selina ^a   Acosta, Juan Carlos ^a   Innes, Andrew J ^a   Banito, Ana ^a   Georgilis, Athena ^a   Montoya, Alex ^a   Wolter, Katharina ^c   Dharmalingam, Gopuraja ^a   Faull, Peter ^a   Carroll, Thomas ^a   Martínez Barbera, Juan Pedro ^d   Cutillas, Pedro ^a,i   Reisinger, Florian ^e   Heikenwalder, Mathias ^e,f   Miller, Richard A ^g   Withers, Dominic ^a   Zender, Lars ^c   Thomas, Gareth J ^b   Gil, Jesús ^a   more..

^a MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY OF MICHIGAN   (United States)

^h GENOME INSTITUTE OF SINGAPORE   (Singapore)

ⁱ QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED PROTEIN KINASE 2; PROTEIN ZFP36L1; RAPAMYCIN; RNA BINDING PROTEIN; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE; UNCLASSIFIED DRUG; MAP-KINASE-ACTIVATED KINASE 2; MTOR PROTEIN, HUMAN; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; PROTEOME; SIGNAL PEPTIDE; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL AGING; CELL CYCLE ARREST; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSLATION INITIATION; TRANSLATION REGULATION; ANIMAL; CANCER TRANSPLANTATION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; NUDE MOUSE; PHYSIOLOGY; PROTEIN SYNTHESIS; SECRETION (PROCESS); TUMOR CELL LINE;

ANIMALS; CELL AGING; CELL LINE, TUMOR; FEMALE; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHOSPHOPROTEINS; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; PROTEOME; TOR SERINE-THREONINE KINASES;

EID: 84940587703     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/s41556-024-01443-6     Document Type: Erratum

References (57)

1. Collado, M., Blasco, M. A., & Serrano, M. Cellular senescence in cancer and aging. Cell. 130, 223-233 (2007
2. Salama, R., Sadaie, M., Hoare, M., & Narita, M. Cellular senescence and its effector programs. Genes Dev. 28, 99-114 (2014
3. Coppe, J. P., Desprez, P. Y., Krtolica, A., & Campisi, J. The senescence-Associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99-118 (2010
4. Kuilman, T., & Peeper, D. S. Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer. 9, 81-94 (2009
5. Krtolica, A., Parrinello, S., Lockett, S., Desprez, P. Y., & Campisi, J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl Acad. Sci. USA. 98, 12072-12077 (2001
6. Acosta, J. C., et al A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15, 978-990 (2013
7. Acosta, J. C., et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell. 133, 1006-1018 (2008
8. Hoenicke, L., & Zender, L. Immune surveillance of senescent cells-biological significance in cancer-And non-cancer pathologies. Carcinogenesis. 33, 1123-1126 (2012
9. Kuilman, T., et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 133, 1019-1031 (2008
10. Jing, H., et al. Opposing roles of NF-B in anti-cancer treatment outcome unveiled by cross-species investigations. Genes Dev. 25, 2137-2146 (2011
11. Chien, Y., et al. Control of the senescence-Associated secretory phenotype by NF-B promotes senescence and enhances chemosensitivity. Genes Dev. 25, 2125-2136 (2011
12. Freund, A., Patil, C. K., & Campisi, J. p38MAPK is a novel DNA damage responseindependent regulator of the senescence-Associated secretory phenotype. EMBO J 30 1536-1548 2011
13. Di Micco, R., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature. 444, 638-642 (2006
14. Rodier, F., et al. Persistent DNA damage signalling triggers senescence-Associated inflammatory cytokine secretion. Nat. Cell Biol. 11, 973-979 (2009
15. Narita, M., et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science. 332, 966-970 (2011
16. Laplante, M., & Sabatini, D. M. mTOR signaling in growth control and disease. Cell. 149, 274-293 (2012
17. Ma, X. M., & Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307-318 (2009
18. Ruvinsky, I., & Meyuhas, O. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem. Sci. 31, 342-348 (2006
19. Richter, J. D., & Sonenberg, N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature. 433, 477-480 (2005
20. Thoreen, C. C., et al A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485 109-113 2012
21. Harrison, D. E., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 460, 392-395 (2009
22. Iglesias-Bartolome, R., et al. mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell. 11, 401-414 (2012
23. Dorr, J. R., et al. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature. 501, 421-425 (2013
24. Acosta, J. C., Snijders, A. P., & Gil, J. Unbiased characterization of the senescenceassociated secretome using SILAC-based quantitative proteomics. Methods Mol. Biol. 965, 175-184 (2013
25. Cutillas, P. R., & Vanhaesebroeck, B. Quantitative profile of five murine core proteomes using label-free functional proteomics. Mol. Cell. Proteomics. 6, 1560-1573 (2007
26. Baker, D. J., et al. Clearance of p16Ink4a-positive senescent cells delays ageingassociated disorders. Nature. 479, 232-236 (2011
27. Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J. Clin. Invest. 123, 966-972 (2013
28. Pospelova, T. V., et al. Suppression of replicative senescence by rapamycin in rodent embryonic cells. Cell Cycle. 11, 2402-2407 (2012
29. Demidenko, Z. N., et al. Rapamycin decelerates cellular senescence. Cell Cycle. 8, 1888-1895 (2009
30. Bundscherer, A., Vogt, T., Kohl, G., Landthaler, M., & Hafner, C. Antiproliferative effects of rapamycin and celecoxib in angiosarcoma cell lines. Anticancer Res. 30, 4017-4023 (2010
31. Dowling, R. J., et al. mTORC1-mediated cell proliferation, but not cell growth, controlled by the. 4E-BPs. Science. 328, 1172-1176 (2010
32. Dieterich, D. C., Link, A. J., Graumann, J., Tirrell, D. A., & Schuman, E. M. Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT). Proc. Natl Acad. Sci. USA. 103, 9482-9487 (2006
33. Casado, P., et al. Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci. Signal. 6, rs6 (2013
34. Gaestel, M. MAPKAP kinases-MKs-Twos company, threes a crowd. Nat. Rev. Mol. Cell Biol. 7, 120-130 (2006
35. Hsieh, A. C., et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 485, 55-61 (2012
36. Young, A. R., et al. Autophagy mediates the mitotic senescence transition. Genes Dev. 23, 798-803 (2009
37. Ross, C. R., Brennan-Laun, S. E., & Wilson, G. M. Tristetraprolin: roles in cancer and senescence. Ageing Res. Rev. 11, 473-484 (2012
38. Ciais, D., et al. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene. 23, 8673-8680 (2004
39. Maitra, S., et al. The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-Activated protein kinase-Activated protein kinase. 2. RNA. 14, 950-959 (2008
40. Ciais, D., Cherradi, N., & Feige, J. J. Multiple functions of tristetraprolin/TIS11 RNAbinding proteins in the regulation of mRNA biogenesis and degradation. Cell. Mol. Life Sci. 70, 2031-2044 (2013
41. Benjamin, D., Schmidlin, M., Min, L., Gross, B., & Moroni, C. BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites. Mol. Cell. Biol. 26, 9497-9507 (2006
42. Spasic, M., et al. Genome-wide assessment of AU-rich elements by the AREScore algorithm. PLoS Genet. 8, e1002433 (2012
43. Tan, F. E., & Elowitz, M. B. Brf1 posttranscriptionally regulates pluripotency and differentiation responses downstream of Erk MAP kinase. Proc. Natl Acad. Sci. USA. 111, E1740-E1748 (2014
44. Kang, T. W., et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature. 479, 547-551 (2011
45. Franceschi, C., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128, 92-105 (2007
46. Banito, A., et al. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 23, 2134-2139 (2009
47. Barradas, M., et al. Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev. 23, 1177-1182 (2009
48. Fellmann, C., et al. An optimized microRNA backbone for effective single-copy RNAi. Cell Rep. 5, 1704-1713 (2013
49. Debacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J., & Toussaint, O. Protocols to detect senescence-Associated β-galactosidase (SA-gal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 4, 1798-1806 (2009
50. Bishop, C. L., et al. Primary cilium-dependent and-independent Hedgehog signaling inhibits p16(INK4A). Mol. Cell. 40, 533-547 (2010
51. Larsen, M. R., Thingholm, T. E., Jensen, O. N., Roepstorff, P., & Jorgensen, T. J. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol. Cell. Proteomics. 4, 873-886 (2005
52. Montoya, A., Beltran, L., Casado, P., Rodriguez-Prados, J. C., & Cutillas, P. R. Characterization of a TiO2 enrichment method for label-free quantitative phosphoproteomics. Methods. 54, 370-378 (2011
53. Alcolea, M. P., Casado, P., Rodriguez-Prados, J. C., Vanhaesebroeck, B., & Cutillas, P. R. Phosphoproteomic analysis of leukemia cells under basal and drug-Treated conditions identifies markers of kinase pathway activation and mechanisms of resistance. Mol. Cell. Proteomics. 11, 453-466 (2012
54. Hornbeck, P. V., et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-Translational modifications in man and mouse. Nucleic Acids Res. 40, D261-D270 (2012
55. Wilkinson, J. E., et al. Rapamycin slows aging in mice. Aging Cell. 11, 675-682 (2012
56. Miller, R. A., et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J. Gerontol. A. 66, 191-201 (2011
57. Orimo, A., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 121, 335-348 (2005